Related Experiment Video
Updated: May 7, 2026
06:24
Generic Protocol for Optimization of Heterologous Protein Production Using Automated Microbioreactor Technology
Published on: December 15, 2017
Studies on process optimization methods for rapamycin production using Streptomyces hygroscopicus ATCC 29253.
Rupika Sinha1, Shalini Singh, Pradeep Srivastava
1School of Biochemical Engineering, Indian Institute of Technology (Banaras Hindu University), Varanasi, 221005, India.
Bioprocess and Biosystems Engineering
|September 20, 2013
Summary
Researchers optimized rapamycin production by Streptomyces hygroscopicus using nutrient adjustments. This enhanced rapamycin yield significantly, paving the way for industrial applications.
Area of Science:
- Microbiology
- Biotechnology
- Fermentation Technology
Background:
- Rapamycin is a valuable immunosuppressant with limited industrial production due to low yields.
- Optimizing fermentation parameters is crucial for enhancing rapamycin production by Streptomyces hygroscopicus.
Purpose of the Study:
- To improve rapamycin production by optimizing nutrient requirements for Streptomyces hygroscopicus NRRL 5491.
- To investigate the role of L-lysine as a precursor in rapamycin biosynthesis.
Main Methods:
- One-at-a-time parameter optimization followed by a hybrid methodology.
- Screening significant factors using Plackett-Burman design (PBD).
- Modeling rapamycin production with artificial neural networks (ANN) and optimizing with genetic algorithms (GA).
Main Results:
- L-lysine addition significantly increased rapamycin production.
- PBD identified mannose, soyabean meal, and L-lysine as key factors.
- ANN-GA optimization achieved a rapamycin yield of 320.89 mg/L.
Conclusions:
- Optimized nutrient medium significantly enhances rapamycin production.
- The developed methodology is effective for improving rapamycin yield.
- The findings support the scale-up for industrial rapamycin production.
Related Concept Videos
01:27Upstream Processing
Upstream processing represents a critical phase in biomanufacturing, wherein biological systems such as microorganisms, mammalian cells, or insect cells are cultivated to produce therapeutic proteins, vaccines, enzymes, or other biologically derived products. This phase encompasses all steps from the selection and genetic manipulation of the production organism to the cultivation of cells in bioreactors under tightly controlled environmental conditions.Host Selection and Genetic OptimizationThe...
01:22Bioreactor Controls-III
Strain improvement is a foundational strategy in industrial microbiology aimed at maximizing microbial productivity, particularly because natural isolates typically yield commercially valuable products in very low concentrations. Although optimizing the culture medium and environmental conditions can improve yields, these adjustments are inherently limited by the organism’s genetic potential. As a result, the focus shifts toward genetic modifications to enhance biosynthetic capacity. The...
01:27Production of Antibiotics
Penicillin, one of the earliest and most widely used antibiotics, is produced industrially by the filamentous fungus Penicillium chrysogenum. Large stirred-tank bioreactors ranging from tens to hundreds of thousands of liters maintain tightly controlled temperature, pH, and dissolved oxygen conditions to support fungal metabolism and maximize antibiotic yield. Penicillin is a secondary metabolite, synthesized primarily during the stationary growth phase, which requires a carefully managed...
01:30Production of Pharmaceuticals
Industrial insulin production uses genetically engineered E. coli expressing a proinsulin gene controlled by a tryptophan promoter and containing a methionine linker for later cleavage. The cells also carry ampicillin resistance for selective growth. Seed cultures are stored at −80 °C and production begins by thawing a small amount to inoculate starter cultures, which are progressively scaled to a 50,000-L bioreactor. In the bioreactor, E. coli grow in nutrient-rich media under sterile, tightly...